ARCHIVES

In Brief: Four To Share In $100,000 Hammer Prize; Oldham To Head New Genetic Engineering Firm In Texas

This article is from The Cancer Letter archive.

Vol. 10 No. 05 | February 3, 1984

Download PDF Visit The Full Archive

Related Articles

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

NCI Won’t Recognize Wolmark Wile NSABP is Plaintiff In Suit

November 18, 1994

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It

February 6, 1976

NIH Advisors Suggest Revamping Grant Application Review

June 14, 1996

Nurses Pass Resolution To Support Research on Ethnic Patient Issues

May 29, 1992